Skip to main content
. Author manuscript; available in PMC: 2021 Apr 12.
Published in final edited form as: Crit Rev Oncog. 2019;24(2):105–118. doi: 10.1615/CritRevOncog.2019031417

FIG. 2:

FIG. 2:

Vaccines against tumor cells. Tumor associated antigens (TAAs) are extracted from tumor cells and used to create vaccines. Once injected, the TAAs in the vaccine activate T-cells specifically against the tumor cells.